Skip to main content

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent

Abstract

Background

He’s team have recently developed a new Coronary Artery Tree description and Lesion EvaluaTion (CatLet) angiographic scoring system, which is capable of accounting for the variability in coronary anatomy, and risk-stratifying patients with coronary artery disease. Preliminary studies have demonstrated its superiority over the the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score with respect to outcome predictions for acute myocardial infarction (AMI) patients. However, there are fewer studies on the prognostic in chronic coronary artery disease(CAD). This study aimed to clarify whether the CatLet score had a predictive value for in-stent restenosis(ISR) in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent(DES).

Methods

A total of 260 patients who were diagnosed with chronic CAD and underwent coronary DES implantation at the second affiliated Hospital of Wannan medical college in China were consecutively enrolled from January 2020 to June 2021.Finally, 164 patients underwent the second angiography after 2 years.According to whether ISR was detected at follow-up angiography, patients were divided into the ISR group (n = 26) and the non-ISR group (n = 139).

Results

A total of 165 patients (46 women and 119 men) with a mean ages of 66.19 ± 10.54 years were finally enrolled in this study. Of these, ISR occurred in 26/165 chronic CAD patients (15.76%) by follow-up angiography. Univariate analysis showed that most baseline characteristics of the ISR and non-ISR group were similar. Patients in the ISR group had significantly the history of chronic obstructive pulmonary disease(COPD), adverse lesion characteristic, higher Catlet score compared with patients in the non-ISR group.The CatLet score was capable of predicting in-stent restenosis after adjustment for risk factors; The Multivariable-adjusted model showed good calibration and good discrimination (area under ROC curve = 0.7164) for ISR.

Conclude

CatLet score is a new predictor of ISR in patients with chronic CAD after coronary DES implantation.

Peer Review reports

Introduction

Coronary heart disease has become the most major factors endangering people’s health.Currently, Percutaneous coronary intervention(PCI) therapy has been the major therapeutic procedure for coronary artery disease (CAD) [1, 2]. With the innovation of stent technology, the restenosis rate of new-generation drug-eluting stents has significantly decreased [3].However, several large-scale clinical trials have confirmed that even in the era of drug-eluting stents (DES), in-stent restenosis (ISR) occurs in 3–20% of patients after coronary stenting implantation [4], which remains an unresolved clinical problem in clinical practice.Therefore, exploring the reliable risk factors for predicting ISR would be of great significant for patients risk assessment.

The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score, an anatomic coronary scoring system, has been developed to grade the severity and complexity of coronary artery disease (CAD) [5]. However, the SYNTAX score, solely based on the dichotomized left or right coronary dominance, has failed to adequately describe the variability of coronary anatomy [6, 7]. Recently, a new Coronary Tree Description and Lesion Assessment CatLet Coronary Scoring System has been developed, which is unique in that it can interpret coronary variants, record the severity of diseased coronary arteries, and semiquantify the range of blood supply to diseased vessels [8]. And previous studies have shown that the CatLet score has a good predictive value for the risk assessment of patients with acute myocardial infarction [9, 10].However, the risk predictors of ISR in chronic CAD patients had not been well characterized.

Therefore, our study aims to explore whether the CatLet score had a predictive value for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent .

Methods

Study patients

A total of 260 patients who were diagnosed with chronic CAD and underwent coronary DES implantation at the second affiliated Hospital of Wannan medical college in China were consecutively enrolled from January 2020 to June 2021.Of these, 200 of these patients who met the inclusion and exclusion criteria were followed up by angiography after baseline PCI.Finally, 164 patients underwent the second angiography after 2 years. Exclusion criteria as follow: (1)patients who died during follow-up(n = 2);(2) patients with myocardial infarction (MI) within one month of baseline PCI (to exclude potential subacute stent thrombosis of the intervened arterial segment)(n = 1);(3) patients without sufficient clinical and angiographic data at baseline and follow up (n = 92). 26 patients with 46 lesions were treated with repeat DES (re-DES) or DCB implantation after the occurrence of ISR in the target vessels.Maintenance drug therapy was routinely administered unless otherwise contraindicated. Dual antiplatelet treatments were strongly recommended for at least 6 months.

This study was approved by the Clinical Research Ethics Committee of the second affiliated Hospital of Wannan medical college, and All patients gave written informed consent.

The CatLet score and the lesion evaluation

The CatLet angiographic scoring system has been described elsewhere in detail [8].Its tutorial is available at http://www.Catletscore.com (Internet Explorer or Microsoft Edge browser is required). In short, this novel angiographic scoring system has adequately accounted for the variability in the coronary trees, where six types of the right coronary artery (RCA), three types of the left anterior descending artery (LAD), and three types of the diagonal branch were reclassified, resulting in a total of 54 (6 × 3 × 3) types of coronary circulation pattern. The weighting of a coronary artery depends on the myocardial territory subtended by the coronary artery. The lesion is defined as > 50% diameter stenosis on vessels ≥ 1.5 mm in diameter. The lesion scoring is a product of the stenosis.

degree and the weighting of the coronary artery involved. Scoring points for multiple lesions were added to derive the total score for a patient. The adverse characteristics pertinent to those lesions were not scored anymore, but rather recorded qualitatively. Non-occlusive lesions were scored straightforward; for a total occlusive lesion, wiring/small ballooning was used to improve the blood flow to evaluate the severity of the lesion (scored as a non-occlusive lesion) while persistently poor blood flow that failed to allow adequate visualization of the lesion was scored as a total occlusive one [11]. A multiplication factor of 2.0 is used for non-occlusive lesions and 5.0.

for occlusive lesions. The CatLet score was calculated from the final angiographic results after elective percutaneous revascularization procedures. Two experienced observers reviewed the angiograms. The view of a third analyst was sought in the event of disagreement, and the final decision was made by consensus. The observers were blinded to patients’ clinical characteristics and outcomes.

Disease definitions and endpoints

The primary end point of the study was the occurrence of ISR. ISR was defined as a diameter stenosis of ≥ 50% occurring in the segment inside the stent or a 5 mm proximal or distal to the stent at follow-up angiography [12, 13].According to whether ISR was detected, patients were classified into two groups: the ISR group and the non-ISR group. Target lesion was considered the most severe narrowing, identified by angiographic appearance with Electrocardio-.

graph (ECG) changes. Multivessel disease (MVD) was defined as a diameter stenosis of ≥ 50% occurring in two or more vessels.

Diabetes mellitus was defined as either a previous diagnosis of DM treated with diet, oral agents or insulin or a new diagnosis of DM if FBG ≥ 7.0mmol/L on two occasions during hospitalization [14]. Hypertension was defined by systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg, and/or the use of antihypertensive treatment in the past two weeks [15]. Low.

levels of HDL-C were defined as 1.04 mmol/L [16]. Chronic obstructive pulmonary disease (COPD) was defined as after Inhalation of bronchodilators, FEV1/FVC < 70% indicates the presence of persistent airflow limitation [17].The severity of coronary artery lesions was quantified with Coronary Artery Tree description and Lesion EvaluaTion (CatLet) score, which was calculated using the online calculator for CatLet score.

Data collection

We use a standard case report form to collect patients’ clinical and demographic characteristics, including age, gender, smoking, alcohol consumption, CAD risk factors, medical history, and coronary angiography information at baseline PCI and follow-up. Body measurements such as blood pressure (BP) was taken upon admission. Neutrophil-lymphocyte ratio (NLR) is calculated by neutrophils divided by lymphocyte counts. Coronary angiography data such as CatLet score, minimum stent diameter, average stent length, and stent narrowing percentage, were also recorded by two experienced researchers at baseline and follow-up for coronary angiography analysis.

Sample size estimation and statistical analysis

Statistical analyses and graphics were completed with STATA 15.1 (State Corp LP, College Station, TX, USA). The enrolled sample size calculation has been provided in detail elsewhere [9]. Briefly, according to the published data, the CatLet score is associated with a 1.05-fold increased risk of adverse cardiovascular events per 1 unit higher, and its standard deviation is 12; previously similar study has reported that the failed probability is around 15% at 1.5-year follow-up [18].

Continuous variables following a normal distribution are represented by mean ± standard deviation. The t-test is used for comparing differences between two groups, while analysis of variance is used for comparing three or more groups. For continuous data that does not follow a normal distribution, the median (with the interquartile range P25, P75) is used, and the differences are compared using the rank sum test. Categorical variables are represented by frequency (rate), and differences between groups are compared using the chi-square test. We use a multiple logistic stepwise regression model using the stepwise method (entry,0.05; removal,0.05) to select the risk factors for ISR, adjusting for traditional risk factors and other confounding factors. The included variables are age, gender, history of COPD, smoking, alcohol consumption, creatinine, blood lipids, imaging indicators, Catlet score, and other biochemical indicators (uric acid, NLR), among others. The Odds ratio (OR) and 95% confidence intervals (95% CI) were calculated to estimate the adjusted risk of ISR in chronic CAD patients. The predictive value of the Logistic regression model was evaluated using Decision Curve Analysis(DCA) .Differences are considered statistically significant when P < 0.05.

Results

Out of 260 patients initially enrolled in this study, 95 were excluded, and 165 patients were finally analyzed as shown in Fig. 1. The mean age was 66.19 ± 10.54 years, and 71.95% (118/164) were male.The CatLet score ranged from 0 to 92, with a mean ± SD of 34.85 ± 19.47. Angiography result showed that ISR occurred in 26/165 chronic CAD patients (15.76%). According to whether ISR was detected, patients were divided into an ISR group (n = 26) and Non-ISR group (n = 139).

Fig. 1
figure 1

Flow chart of patient selection. CAD: coronary artery disease, DES: drug-eluting stent, ISR: in-stent restenosis. 139)

Baseline clinical characteristics

The baseline clinical variables of the patients were listed in Table 1. There were no significant differences between the ISR group and non-ISR group in terms of age, gender, smoking, drinking, history of hypertension or diabetes, and history of chronic kidney disease. Patients in the ISR group had significantly the history of chronic obstructive pulmonary disease(COPD) (26.9% vs. 10.8%, P = 0.026).The levels of Cr, TG, LDL-C, HDL-C, FBG, apob, NLR, and LVEF were similar in both groups.

Table 1 Baseline clinical characteristics of study population

Baseline angiographic characteristics

The baseline angiographic and procedural characteristics of the patients were shown in Table 2. Within bifurated lesions, as Medina110 and Medina011 types was higher in the ISR group than in the non-ISR group (11.5% vs. 2.9%, P = 0.044) (26.9% vs. 10.8%, P = 0.026). The Catlet score in the ISR group was also significantly higher than in the non-ISR group (44.23 ± 24.53 vs. 33.09 ± 17.94, P = 0.007). Other basic vascular imaging information, such as target vessels, coronary artery classification, advere lesion characteristic, minimum stent diameter, and stent length, did not show significant differences between the two groups.

Table 2 Baseline angiographic characteristics of study population

Predictors of ISR in CAD

In the multivariate logistic regression analysis model, after adjusting for a history of COPD, stent number, Catlet score, and the bifurated lesions as Medina110 and Medina011,CatLet score remains to be a predictors associated with ISR in coronary heart disease patients as shown in supplementary Table 1. Adjusted CatLet score performed well in discrimination with respect to clinical outcomes as shown in Fig. 2. Areas under the receiver operating characteristic (ROC) curve ranged between 0.72.

Fig. 2
figure 2

The ROC curves of Catlet alone and adjusted Catlet models for ISR; AUC, Receiver Operating Characteristic (ROC) curve; and CI, confidence interval.CS: Catlet score, Adj-CS: adjusted Catlet score

Calibration

In terms of calibration, the model with the CatLet score and Adjusted Catlet score was robust as shown in Fig. 3.

Fig. 3
figure 3

Calibration plots of CatLet score and adjusted CatLet score at cross-validation with respect to ISR for CatLet score (A) and adjusted CatLet score (B). A blue lowess smoothing curve was added to each calibration plot. Intercept of 0 and slope of 1 indicate perfect prediction. Negative and positive intercepts indicate overestimation and underestimation, respectively

Subgroup analysis

Subgroup analysis had demonstrated that the CatLet score was a consistent hazard risk for ISR although the CatLet score interacts with diabetes, which deserved further study as shown in Fig. 4.

Fig. 4
figure 4

Hazard ratios for ISR per 1 units higher CatLet score stratified by risk factors, categorically or medially, adjusted for meaningful factors. LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein cholesterol; TG, triglycerides; and TC, total cholesterol

Discussion

The results of this study as follow: (a) the CatLet score in isolation independently predicted ISR clinical outcomes; (b) the CatLet score remained significantly predictive of ISR even after adjustment for important clinical explaining variables,

Percutaneous coronary intervention(PCI) had become the major theraputic procedure for coronary artery disease(CAD), and with the improvement and advancement of stent technology, studies have shown that the incidence of in-stent restenosis (ISR) with third-generation drug-eluting stents (DES) is less than 10% [19].However, with the increasing complexity of procedures (such as more complex patients and coronary lesions), the incidence of in-stent restenosis (ISR) is also on the rise.The study shed light on that ISR occurred in 26/165 chronic CAD patients (15.76%) by follow-up angiography.It may be due to: the research results bias caused by a relatively small sample size; the patients enrolled with more complex lesions, such as a higher proportion of bifurcation lesions and long lesions, which could increase the intraoperative injury to the vascular endothelium during PCI and thereby increase the risk of ISR.

Research showed that individuals diagnosed with COPD are at a higher risk of developing adverse cardiovascular outcomes [20].Chronic inflammation in COPD has been found to involve both innate and adaptive immunity [21]. Previous studies found that patients with a history of COPD have an increased risk of ISR after receiving drug-eluting stent implantation(OR = 2.44, 95% CI: 1.33–4.49, P = 0.004) [22, 23]. In the current study, A history of COPD manifested as the strongest predictor of clinical outcomes to be incorporated to construct the final multivariate adjusted models.

A lesion that causes coronary artery flow limitation has been considered as an important prognostic factor [24]. The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score, an anatomic coronary scoring system, has been developed to grade the severity and complexity of coronary artery disease (CAD). However, the SYNTAX score, solely based on the dichotomized left or right coronary dominance, has failed to adequately describe the variability of coronary anatomy. Although the SYNTAX score has been widely used in risk stratification and selection of revascularization strategies, there are studies questioning its predictive value in CAD patients.He’s team developed a novel Coronary Artery Tree description and Lesion EvaluaTion (CatLet) angiographic scoring system, which can be utilized to account for the variability in coronary anatomy, and to risk-stratify patients with CAD [8]. In previous studies, various model designs have shown that the CatLet score is better than the SYNTAX score for the long-term prognosis of patients with acute coronary syndrome [25, 26]. In the current study, higher CatLet scores were associated with a higher incidence of ISR(Odds ratio/unit higher score were 1.03,P < 0.05).This is consistent with the results of our previous studies of Catlet scores in chronic coronary syndrome [27].

Limitation

This study has several limitations. First, the CatLet score validation trial is observational in design, and the confounding is unavoidable. Thus, this finding should be considered hypothesis-generating. Second, a single-center study with a small sample size is still a concern, which would have weakened the statistical power of the conclusions. Third, like the SYNTAX score, lesions with diameter stenosis ≥ 50% were scored in the CatLet score.However, only 35% of the intermediate (50–70%) angiographic.

stenosis was hemodynamically relevant as defined by fractional flow reserve (FFR) ≤ 0.80 [28]. Further studies are needed to clarify whether the FFR-guided CatLet score is a better predictor of prognosis than the one just based on the visual assessment.

Conclusion

In the present study, we have demonstrated that the CatLet score has a predicting value for ISR in patients with CAD after coronary DES implantation.

Data availability

Data is provided within the manuscript.

References

  1. Liu Y, Xu C, Fu P, et al. Family history of myocardial infarction as a strong independent predictor of in-stent restenosis in the era of drug eluting stents. Int J Cardiol. 2015;179:55–7.

    Article  PubMed  Google Scholar 

  2. Demyanets S, Tentzeris I, Jarai R, et al. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. Cytokine. 2014;67:65–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Piraino D. Paclitaxel eluting balloon and sirolimus eluting balloon,many weapons against a common enemy: the in-stent restenosis[J]. Int J Cardiol. 2017;242:4.

    Article  PubMed  Google Scholar 

  4. Torrado J, Buckley L, Durán A, et al. Restenosis, stent thrombosis,and bleeding complications: navigating between Scylla and Charybdis[J]. J Am Coll Cardiol. 2018;71(15):1676–95.

    Article  PubMed  Google Scholar 

  5. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219–27.

    PubMed  Google Scholar 

  6. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981;63:285–99.

    Article  CAS  PubMed  Google Scholar 

  7. He YM, Shen L, Ge JB. Fallacies and possible remedies of the SYNTAX score. J Interv Cardiol. 2020;2020:8822308.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Xu MX, Teng RL, Ruddy TD, Schoenhagen P, Bartel T, Di Bartolomeo R, et al. The CatLet score: a new coronary angiographic scoring tool accommodating the variable coronary anatomy for the first time. J Thorac Dis. 2019;11:5199–209.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Xu MX, Ruddy TD, Schoenhagen P, Bartel T, Di Bartolomeo R, von Kodolitsch Y, et al. The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: a proof of-concept study. Catheter Cardiovasc Interv. 2020;96:E220–9.

    Article  PubMed  Google Scholar 

  10. Wang H, He Y, Fan JL, et al. The predictive value of CatLet© angiographic scoring system for long-term prognosis in patients with acute myocardial infarction presenting > 12 h after symptom onset. Front Cardiovasc Med. 2022;9:943229.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Magro M, Räber L, Heg D, Taniwaki M, Kelbaek H, Ostojić M, et al. The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial. Int J Cardiol. 2014;175:314–22.

    Article  PubMed  Google Scholar 

  12. Pan J, Lu Z, Zhang J, et al. Angiographic patterns of in-stent restenosis classified by computed tomography in patients with drug-eluting stents: correlation with invasive coronary angiography. Eur Radiol. 2013;23:101–7.

    Article  PubMed  Google Scholar 

  13. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659–73.

    Article  PubMed  Google Scholar 

  14. Report of the expert committee on the. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–20.

    Google Scholar 

  15. Mansia G, De Backer G, Dominiczak A, et al. 2007 ESH ESC guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16:135–232.

    Article  PubMed  Google Scholar 

  16. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol. 2004;44:720–32.

    Article  PubMed  Google Scholar 

  17. Global Initiative for Chronic Obstructive Lung Disease. (GOLD 2016) Global strategy for the diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease Accessed June 25, 2017 www.goldcopd.org.

  18. Liu JM, He Y, Teng RL, Qian XD, Dai YL, Xu JP, et al. Inter- and intra-observer variability for the assessment of coronary artery tree description and lesion EvaluaTion (CatLet©) angiographic scoring system in patients with acute myocardial infarction. Chin Med J (Engl). 2020;134:425–30.

    Article  PubMed  Google Scholar 

  19. Atsushi S. Yu Sato,Rika Kawakami,etc.Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents:current clinical approaches and challenges[J].2021,19(9).

  20. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.

    Article  PubMed  Google Scholar 

  21. Hogg JC, Pare PD, Hackett T-L. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Rev Physiol Rev. 2017;97(2):529–52.

    Article  PubMed  Google Scholar 

  22. Hou L, Su K, Zhao J, Li Y. Predictive value of COPD History on In-Stent restenosis in coronary arteries following percutaneous coronary intervention. Int J Gen Med. 2023;16:3977–84.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rafał Januszek Z, Siudak, Artur Dziewierz. Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions. POLISH ARCHIVES OF INTERNAL MEDICINE.2018;128(1):24–34.

  24. van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, Engstrøm T, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. 2015;386:1853–60.

    Article  PubMed  Google Scholar 

  25. Xu M, Wang S, Zhang Y, et al. Residual coronary artery tree description and lesion EvaluaTion (CatLet) score, clinical variables, and their associations with outcome predictions in patients with acute myocardial infarction. Chin Med J (Engl). 2023;136(20):2459–67.

    CAS  PubMed  Google Scholar 

  26. He YM, Masuda S, Jiang TB, Xu JP, Sun BC, Ge JB. CatLet score and clinical CatLet score as predictors of long-term outcomes in patients with acute myocardial infarction presenting later than 12 hours from symptom onset. Ann Med. 2024;56(1):2349190.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wang J, Xu MX, Zhang MC, Zhou, JY,Lu. DS,the predictive value of the CatLet scoring system for long-term prognosis after percutaneous coronary intervention in patients with chronic coronary syndrome.Catheter Cardiovasc Interv. (2024) https://doiorg.publicaciones.saludcastillayleon.es/10.1002/ccd.31191

  28. Miller J, White J, Hashemi J, Ghafghazi S, Berson RE. Coronary Flow Rate adds predictive capability for FFR Assessment. Res Sq. 2023.

Download references

Acknowledgements

Not applicable.

Funding

This work was in part supported by College of Natural Science Funds and Wuhu city Program for the Cultivation of High-Level Innovative Health Talents.

Author information

Authors and Affiliations

Authors

Contributions

JW and MCZ the co-first authors, developed treatment plan for the patient and wrote the manuscript. JYZ, WPG, MXX, performed follow-up for patient. LFY and YSK, the co-corresponding author, modify the manuscript, and made the illustrations. All authors read and approved the final manuscript. All authors agreed to their contribution.

Corresponding author

Correspondence to Yongsheng Ke.

Ethics declarations

Ethics approval and consent to participate

Ethical review and informed consent of patients have been obtained.

Consent for publication

Written informed consent was obtained from the patient for publication of this article and any accompanying images.A copy of written consent is available for review by the Editor this journal.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Lingfei Yang and Yongsheng Ke the co-corresponding author.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Zhang, M., Gan, W. et al. Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent. J Cardiothorac Surg 20, 106 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-025-03349-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-025-03349-2

Keywords